Science Explorer Interactive view Map
Topic · Immunology

Mast cells and histamine

Mast cells and histamine is a research topic within Immunology. Science Explorer counts 26k research works in it since 1950. 14.6% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the diverse roles of mast cells in allergic disease, immune responses, and inflammation. It covers topics such as the activation and regulation of mast cells, their interactions with other immune cells, their involvement in allergic and non-allergic immune responses, and their significance in diseases such as mastocytosis. The cluster also delves into the molecular mechanisms, signaling pathways, and therapeutic implications related to mast cell biology.

  • Mast Cells
  • Allergic Disease
  • Immune Responses
  • Histamine
  • Basophils
  • T Cell Activation
  • Inflammation
  • Cytokines
  • Receptor Tyrosine Kinase
  • Mastocytosis
Research works
26k
fractional, since 1950
In the world top 10%
3.8k
per year above
Top-10% rate
14.6%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+5%
the tick is no change

Which countries lead Mast cells and histamine research?

By volume, the United States and China publish the most (680 and 470 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 680 works
  2. 2 China 470 works
  3. 3 Japan 176 works
  4. 4 Germany 167 works
  5. 5 India 149 works
  6. 6 Italy 134 works
  7. 7 France 113 works
  8. 8 United Kingdom 95 works
  9. 9 South Korea 84 works
  10. 10 Spain 80 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.7%China: 21.9%Japan: 8.2%Germany: 7.8%6 others listed: 30.5%32%largest
United States680 · 31.7%China470 · 21.9%Japan176 · 8.2%Germany167 · 7.8%6 others listed653 · 30.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Mast cells and histamine research?

By volume in 2022–2025, Charité - Universitätsmedizin Berlin publishes the most Mast cells and histamine research, followed by University of Michigan and Harvard University.

By volume, 2022–2025

  1. 1 Charité - Universitätsmedizin BerlinGermany 15 works
  2. 2 University of MichiganUnited States 12 works
  3. 3 Harvard UniversityUnited States 11 works
  4. 4 Xi'an Jiaotong UniversityChina 10 works
  5. 5 Brigham and Women's HospitalUnited States 10 works
  6. 6 InsermFrance 10 works
  7. 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 10 works
  8. 8 Humboldt-Universität zu BerlinGermany 9 works
  9. 9 Johns Hopkins UniversityUnited States 9 works
  10. 10 Medical University of ViennaAustria 9 works

Where is Mast cells and histamine research done?

The largest centres of Mast cells and histamine research in 2022–2025 are Beijing (China), Tokyo (Japan), Paris (France) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda and Berlin.

Largest cities, 2022–2025

  1. 1 Beijing China 61 works
  2. 2 Tokyo Japan 53 works
  3. 3 Paris France 51 works
  4. 4 London United Kingdom 36 works
  5. 5 Berlin Germany 36 works
  6. 6 Shanghai China 34 works
  7. 7 Seoul South Korea 33 works
  8. 8 Moscow Russia 33 works
  9. 9 New York United States 32 works
  10. 10 Xi'an China 29 works

Where it is the local speciality

  1. BethesdaUS · 21.2 works5.8×
  2. BerlinDE · 35.6 works4.1×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Mast cells and histamine than the world average.

See Mast cells and histamine on the map

Where is the best place to study Mast cells and histamine?

Among universities, judged by research, Humboldt-Universität zu Berlin, Medical University of Vienna and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.0333%fractional works in this node (log) →share in the world top 10% →Humboldt-Universität zu Berlin: 9, 33.7%Medical University of Vienna: 9, 23.8%Harvard University: 11, 24.8%Karolinska Institutet: 8, 18.1%Johns Hopkins University: 9, 23.5%Xi'an Jiaotong University: 10, 12.2%Chinese Academy of Medical Sciences & Peking Union Medical College: 10, 16.5%University of Michigan: 12, 8.5%University of Pennsylvania: 8, 10.2%Humboldt-Universität…Harvard UniversityMedical University o…Karolinska Institutet
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Humboldt-Universität zu BerlinGermany 64.333.7%8.6×9 —
2 Medical University of ViennaAustria 51.423.8%9.8×9 -38.0%
3 Harvard UniversityUnited States 40.124.8%3.1×11 -21.0%
4 Karolinska InstitutetSweden 34.718.1%6.3×8 -59.3%
5 Johns Hopkins UniversityUnited States 26.823.5%2.9×9 -24.9%
6 Xi'an Jiaotong UniversityChina 26.612.2%2.1×10 +520.9%
7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 26.416.5%3.5×10 +58.3%
8 University of MichiganUnited States 24.48.5%3.0×12 +87.4%
9 University of PennsylvaniaUnited States 7.410.2%3.1×8 -34.8%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Mast cells and histamine research growing?

Output in 2018–2022 was 5% higher than in 2013–2017, peaking in 2009. The fastest-growing topics are Mast cells and histamine.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.